StockNews.com upgraded shares of HIVE Blockchain Technologies (NASDAQ:HIVE – Free Report) to a sell rating in a research note issued to investors on Sunday. HIVE has been the subject of a number of other reports. Canaccord Genuity Group reaffirmed a buy rating and issued a $7.00 price target on shares of HIVE Blockchain Technologies in […]